Go to deals
Healthcare

NordMedica A/S has been acquired by Eurocept B.V.

The Dutch pharmaceutical company Eurocept B.V. has acquired 100% of the share capital in the Danish specialty pharmaceutical company NordMedica A/S for an undisclosed consideration.

NordMedica A/S was founded in 2003 as a privately held specialty pharmaceutical company focused on the commercialization and marketing of niche pharmaceutical products. The company holds the rights to an oncology product under the brand names Amekrin®, Amsidine® and Amsidyl® in more than 25 countries. The product is based on a chemotherapy drug for the treatment of Acute Myeloid Leukemia (AML) and Acute Lymphatic Leukemia (ALL). All other assets and liabilities together with all employees were transferred to NordMedica International before the transaction.

Eurocept is a rapidly growing company active in the pharmaceutical and homecare market in the Benelux countries. Eurocept offers products and services that answer to pharmaceutical, technological and nursing needs in medical care as well as a unique combination of medical technology and distribution in the therapeutic areas of anesthesia, oncology, pediatrics, psychiatry, immunology, ADHD and urology.

Oaklins' team in Denmark acted as financial and strategic advisor to the seller in this transaction.

Service
M&A sell-side
Parties

Talk to the deal team

 Daniel  Sand

Daniel Sand

Partner
Copenhagen, Denmark
Oaklins Beierholm

Related deals

Presmed Australia has been acquired by ICG
Private Equity | Healthcare

Presmed Australia has been acquired by ICG

Advanced Health Limited has sold Presmed Australia Pty Ltd (PMA) to ICG.

Learn more
Pia Mater, a social services firm, has been acquired by SAT Heath
Private Equity | Healthcare

Pia Mater, a social services firm, has been acquired by SAT Heath

The founders of Pia Mater Ltd. have sold the company to SAT Health.

Learn more
DIAGOMICS has been acquired by ZytoMax, supported by healthcare specialist Archimed investment firm
Private Equity | Healthcare

DIAGOMICS has been acquired by ZytoMax, supported by healthcare specialist Archimed investment firm

The owner of DIAGOMICS has sold the company to ZytoMax GmbH.

Learn more